Detalles de la búsqueda
1.
Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer.
BJU Int
; 114(6b): E25-E31, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24298897
2.
Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer.
Clin Genitourin Cancer
; 12(5): 317-24, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24806399
3.
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer.
J Clin Oncol
; 32(2): 76-82, 2014 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24323035
Resultados
1 -
3
de 3
1
Próxima >
>>